(EXX7) iShares Nikkei 225 (DE) - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: DE000A0H08D2

EXX7: Japan, Large-Cap, Equity, Blend

The iShares Nikkei225 UCITS ETF (DE) is a German-based exchange-traded fund that tracks the Morningstar Japan TME NR JPY index, providing investors with exposure to the Japanese large-cap equity market. With a focus on replicating the performance of the underlying index, this ETF offers a diversified portfolio of prominent Japanese companies.

From a technical analysis perspective, the ETFs price action indicates a relatively stable trend, with the short-term Simple Moving Average (SMA20) at 23.18, closely aligned with the last price of 23.19. The medium-term SMA50 at 22.41 suggests a potential support level, while the long-term SMA200 at 23.51 indicates a slightly higher average price over the past year. The Average True Range (ATR) of 0.27, equivalent to 1.17%, implies moderate daily price volatility. Given these technical indicators, a potential trading range could be between 22.50 and 24.00, with a breakout above 24.00 potentially targeting the 52-week high of 25.00.

Fundamentally, the iShares Nikkei225 UCITS ETF (DE) boasts an impressive Assets Under Management (AUM) of approximately 28.25 billion EUR, indicating significant investor interest and liquidity. As the ETF is designed to mirror the Morningstar Japan TME NR JPY index, its performance is closely tied to the overall Japanese equity market, which is influenced by factors such as economic growth, monetary policy, and global trade dynamics.

Combining technical and fundamental insights, a potential forecast for the iShares Nikkei225 UCITS ETF (DE) could be: if the ETF breaks above the 24.00 level and sustains its momentum, it may continue to rise towards the 52-week high of 25.00, driven by a potential strengthening of the Japanese economy and favorable market sentiment. Conversely, a decline below the SMA50 at 22.41 could signal a potential correction, potentially targeting the 52-week low of 19.84. Investors should closely monitor the ETFs price action, as well as broader market trends, to make informed investment decisions.

Additional Sources for EXX7 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EXX7 ETF Overview

Market Cap in USD 32,599m
Category Japan Large-Cap Blend Equity
IPO / Inception 2006-07-05

EXX7 ETF Ratings

Growth Rating 31.5
Fundamental -
Dividend Rating 33.0
Rel. Strength -20.9
Analysts -
Fair Price Momentum 21.01 EUR
Fair Price DCF -

EXX7 Dividends

Dividend Yield 12m 0.95%
Yield on Cost 5y 1.29%
Annual Growth 5y 0.91%
Payout Consistency 91.2%
Payout Ratio %

EXX7 Growth Ratios

Growth Correlation 3m 29.7%
Growth Correlation 12m -1.6%
Growth Correlation 5y 58.9%
CAGR 5y 6.05%
CAGR/Max DD 5y 0.28
Sharpe Ratio 12m 0.30
Alpha -8.91
Beta 0.914
Volatility 13.92%
Current Volume 8.2k
Average Volume 20d 2.4k
What is the price of EXX7 shares?
As of June 16, 2025, the stock is trading at EUR 23.01 with a total of 8,225 shares traded.
Over the past week, the price has changed by -1.20%, over one month by -1.24%, over three months by -0.90% and over the past year by +2.42%.
Is iShares Nikkei 225 (DE) a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares Nikkei 225 (DE) is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 31.48 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXX7 is around 21.01 EUR . This means that EXX7 is currently overvalued and has a potential downside of -8.69%.
Is EXX7 a buy, sell or hold?
iShares Nikkei 225 (DE) has no consensus analysts rating.
What are the forecasts for EXX7 share price target?
According to our own proprietary Forecast Model, EXX7 iShares Nikkei 225 (DE) will be worth about 23.9 in June 2026. The stock is currently trading at 23.01. This means that the stock has a potential upside of +3.82%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 23.9 3.8%